Atherosclerosis
Atherosclerosis has a complementary open access journal called Atherosclerosis: X, which shares identical goals, editorial team, submission process, and a thorough peer review system. The journal Atherosclerosis publishes research from various sources that focus on the study of atherosclerosis, its risk factors, and clinical implications. It includes a wide range of research approaches, from basic and translational studies to clinical and population-based investigations related to arterial and vascular health. Topics covered also include important risk factors such as issues with lipid and lipoprotein metabolism, diabetes, hypertension, thrombosis, and inflammation. The Editors welcome both original research and review articles that explore the causes, environmental, genetic, and epigenetic factors, diagnosis, or treatment of atherosclerosis and associated conditions, along with their risk factors.
Outlet metrics
Global
#601800
United States
#484506
Health/Health
#8137
Articles
-
Feb 12, 2024 |
atherosclerosis-journal.com | Olufunmilayo H. Obisesan |Ellen Boakye |Frances Wang |Zeina A. Dardari
Background and aims Coronary artery calcium (CAC) is validated for risk prediction among middle-aged adults, but there is limited research exploring implications of CAC among older adults. We used data from the Atherosclerosis Risk in Communities (ARIC) study to evaluate the association of CAC with domains of healthy and unhealthy aging in adults aged ≥75 years. Methods We included 2,290 participants aged ≥75 years free of known coronary heart disease who underwent CAC scoring at study visit 7.
-
Nov 28, 2023 |
atherosclerosis-journal.com | Elias Bjornson |Martin Adiels |Göran Bergström |Region Västra Götaland
Highlights•Liver fat-related genetic variants may or may not raise coronary heart disease risk. •Previous studies have shown different results using different genetic variants. •The effect on apoB-containing lipoproteins may explain previous results. •Here, we were able to directly account for the possible effect on plasma apoB. •We found that the effect on coronary heart disease risk is fully explained by apoB.
-
Aug 31, 2023 |
atherosclerosis-journal.com | Jessica N. Holtzman |Martha Gulati
Highlights•Disparities in management of ASCVD persist between men and women. •Women experience disproportionate delays in the treatment of ACS. •Women receive less guideline-directed medical therapy despite similar efficacy. •Inadequate enrollment of women in clinical trials contributes to treatment gaps. AbstractDisparities between women and men persist in the diagnosis, treatment, and prognosis of atherosclerotic cardiovascular disease (ASCVD).
-
Jun 27, 2023 |
atherosclerosis-journal.com | Dick C. Chan |Leonard Kritharides |Gerald F Watts
Cookie Preference CenterWe use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer.
-
Dec 25, 2022 |
atherosclerosis-journal.com | Qi Lu
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →